Lithium-induced nephrotic syndrome in a young pediatric patient

Pediatr Nephrol. 2002 Apr;17(4):290-2. doi: 10.1007/s00467-001-0809-7.

Abstract

Lithium-induced nephrotic syndrome is a rare complication of lithium therapy and is even rarer in children. Most reported cases have been secondary to minimal change disease, which reverses within 1-4 weeks on discontinuation of lithium therapy. However, focal glomerulosclerosis (FSGS) has occasionally been reported and is not always reversible with discontinuation of lithium. We report an 11-year-old child with lithium-induced FSGS nephrotic syndrome who went into full remission after lithium was discontinued.

Publication types

  • Case Reports

MeSH terms

  • Antimanic Agents / adverse effects*
  • Antimanic Agents / therapeutic use
  • Bipolar Disorder / drug therapy
  • Child
  • Humans
  • Male
  • Nephrotic Syndrome / chemically induced*

Substances

  • Antimanic Agents